肾癌G250MN/CAIX抗原的研究进展
被引量:3
摘要
肾癌G2 5 0抗原是其特异性抗原 ,相应抗体及瘤苗在动物与临床试验中取得阶段性成果 ,展示了对肾癌的诊断、治疗和监测的良好应用前景。本文对肾癌G2 5 0抗原的蛋白组成、基因结构、理化性质以及在肾癌的诊断。
出处
《国外医学(泌尿系统分册)》
2005年第1期12-16,共5页
Foreign Medical Sciences(Urology and Nephrology Foreign Medical Sciences)
参考文献18
-
1Potter CPS,Harris AL.Diagnostic,prognostic and therapeutic implications on carbonic anhydrases in cancer.Bri J Cancer,2003,89(1):2-7.
-
2Opavsky R,Pastorekova S,Zeinik V,et al.Gene,a novel member of the carbinic angydase familu:structure and exon to protein domain relationships.Genomics,1996,33:480-487.
-
3Grabmaier K,Vissers JL,De Weijert MC,et al.Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250.Int J Cancer,2000,85(6):865-70.
-
4Cho M,Uemura H,Kim SC,et al.Hypomethylation of the MN/CA9 promoter proximal region(SP) and upregulated MN/CA9 expression in human renal cell carcinoma.Br J Cancer,2001,85:563-567.
-
5Vissers JL,De Vries IJ,Engelen LP,et al.Renal cell carcinoma-associated antigen G250 encodes a naturally processed epitope presented by human leukocyte antigen-DR molecules to CD4(+) T lymphocytes.Int J Cancer,2002,100(4):441-4.
-
6Weijtens ME,Hart EH,Bolhuis RL.Functional balance between T cell chimeric receptor density and tumor associated antigen density:CTL mediated cytolysis and lymphokine production.Gene Ther,2000,7(1):35-42.
-
7Grabmaier K,de Weijert M,Uemura H,et al.Renal cell carcinoma-associated G250 methylation and expression:in vivo and in vitro studies.Urology,2002,60(2):357-62.
-
8Brouwers AH,Frielink C,Oosterwijk E,et al.Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX,a potential target for(radio) immunotherapy of renal cell carcinoma.Cancer Biother Radiopharm,2003,18(4):539-47.
-
9Kennett RH.Technology evaluation:WX-G250,Wilex/Ludwig Institute for Cancer Research.Curr Opin Mol Ther,2003,5(1):70-5.
-
10Steffens MG,Boerman OC,Oosterwijk-Wakka JC,et al.Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250.J Clin Oncol,1997,15(4):1529-37.
同被引文献20
-
1李科,苏泽轩,李君武.肾癌生物治疗的研究进展[J].中国医学工程,2008,16(4):279-282. 被引量:1
-
2任淑萍,包木胜,高新,于永利,王丽颖.HSP65-MUC1/HSP65抗体免疫复合物对人树突状细胞的活化作用[J].吉林大学学报(医学版),2005,31(2):182-185. 被引量:6
-
3Bleumer I,Knuth A,Oosterwijk E,et al.A phase Ⅱ trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients.Br J Cancer,2004,90:985-990.
-
4Su Z,Dannull J,Heiser A,et al.Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells.Cancer Res,2003,63:2127-2133.
-
5McKiernan JM,Buttyan R,Bander NH,et al.The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9.Cancer,1999,86:492-497.
-
6Grabmaier K,Vissers JL,De Weijert MC,et al.Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250.Int J Cancer,2000,85:865 -870.
-
7Krutzik SR,Tan B,Li H,et al.TLR activation triggers the rapiddifferentiation of monocytes into macrophages and dendritic cells[J].Nat Med,2005,11(6):653-660.
-
8Reinhard G,Marten A,Kiske SM,et al.Generation of dendriticcell-based vaccines for cancer therapy[J].Br J Cancer,2002,86(10):1529-1533.
-
9Akiyama K,Ebihara S,Yada A,et al.Targeting apoptotic tumorcells to FcγR provides efficient and versatile vaccination againsttumors by dendritic cells[J].J Immunol,2003,170(4):1641-1648.
-
10Dubois B,Lamy PJ,Chemin K,et al.Measles virus exploits den-dritic cells to suppress CD4+T-cell proliferation via expression ofsurface viral lycoproteins independently of T-cell trans-infection[J].Cell Immunol,2001,214(2):173-183.
引证文献3
-
1张亚东,李晓飞,丘少鹏.肾癌淋巴结切除术的进展[J].中山大学研究生学刊(自然科学与医学版),2005,26(4):29-35. 被引量:1
-
2李晓飞,曹开源,徐霖,袁广卿,张亚东,肖娜,刘晓华.肾癌G250抗原基因真核表达载体的构建和序列测定[J].中华泌尿外科杂志,2006,27(1):5-8. 被引量:7
-
3孙海燕,刘晓辉,马楠,王扬,蒋涛,刘云鹏,姜又红.肾癌细胞和G250单克隆抗体复合物致敏树突状细胞肿瘤疫苗的制备[J].中国肿瘤生物治疗杂志,2012,19(1):40-44.
二级引证文献8
-
1冯峰,洪宝发,王晓雄,张彬,白云秀,黄君健.PinX1基因在肾癌组织的表达及临床意义[J].泌尿外科杂志(电子版),2010,2(3):13-18. 被引量:3
-
2李晓飞,刘雷,吴荣佩,张亚东,李乐军,徐秀章,曹开源.肾癌G250 MN/CAIX重组质粒DNA免疫效应的初步研究[J].中山大学学报(医学科学版),2007,28(B06):7-9. 被引量:1
-
3张亚东,吴荣佩,刘雷,李乐,曹开源,李晓飞.肾癌G250抗原基因在sp2/0细胞中的表达及其意义[J].中山大学学报(医学科学版),2008,29(1):16-19. 被引量:1
-
4刘雷,李晓飞,曹开源,吴荣佩,李乐军,张亚东.肾癌G250/MN/CAIX抗原基因在酿酒酵母中的诱导表达及意义[J].中山大学学报(医学科学版),2009,30(1):30-34. 被引量:2
-
5李乐军,刘辉,吴荣佩,曹开源,李晓飞.RNAi沉默G250/MN/CAIX基因对肾癌Ketr-3细胞株生物学行为的影响[J].现代泌尿生殖肿瘤杂志,2009,1(3):169-173.
-
6许长宝,王晓甫.CAIX/MN/G250 mRNA在肾癌根治术前后表达的检测[J].现代泌尿生殖肿瘤杂志,2010,2(1):27-30. 被引量:2
-
7叶烈夫,谢泽铨,崔旭,许庆均,何延瑜,李涛,杨风光,陈新,朱庆国,林乐.碳酸酐酶IX表达在肾透明细胞癌预后评估中的价值[J].中华泌尿外科杂志,2011,32(7):454-458. 被引量:3
-
8王雨生,双卫兵.转移性肾癌患者行转移灶切除术的临床价值[J].泌尿外科杂志(电子版),2019,11(4):9-12. 被引量:2
-
1张亮,田仁礼,阎瑾琦,于继云.肾癌相关抗原G250-MN/CAⅨ在肾癌疫苗和免疫治疗研究中的应用[J].军事医学科学院院刊,2007,31(6):582-585. 被引量:1
-
2姜耀东,任非,郑少斌.MN/CAⅨ在肾细胞癌诊断中的价值[J].南方医科大学学报,2012,32(3):412-414.
-
3王梅,孟华.联合检测CEA、CA724对胃癌的临床意义[J].中国误诊学杂志,2011,11(1):54-55. 被引量:3
-
4杨鹏,王健.前列腺癌肿瘤标志物应用的研究进展[J].现代医药卫生,2012,28(8):1200-1202. 被引量:1
-
5王玉芳,段钊.宫颈癌患者血清DcR_3及SCCA水平及临床意义[J].陕西医学杂志,2014,43(9):1240-1241. 被引量:3
-
6周绍明,马赟,龚颖平,李青春,崔毅,李博,吴湘,唐双玲.血清CA125检测结合CT对卵巢肿瘤的诊断价值[J].医学临床研究,2009,26(12):2257-2258. 被引量:1
-
7毛红丽,王清霞,尹惠卿.肝癌患者血清中AFP、CYFRA21-1和CA19-9水平检测及意义[J].中国误诊学杂志,2009,9(28):6890-6891.
-
8郭英,邹启云,王丽.美罗华治疗B细胞淋巴瘤7例的观察及护理[J].中国误诊学杂志,2005,5(16):3175-3176. 被引量:7
-
9史晓宇(综述),周建华(审校).贝伐单抗治疗转移性结直肠癌[J].国际肿瘤学杂志,2008,35(3):209-211.
-
10黄炎,程丹,杨继元.胃肠道肿瘤的靶向治疗[J].国际肿瘤学杂志,2017,44(1):71-74.